Akston Biosciences files for IPO on NYSE American

Akston Biosciences Corporation announced plans for an initial public offering of 2,222,222 shares of common stock. The company estimates the offering price will range between $8.00 and $10.00 per share.

The biotechnology company has applied to list its shares on the NYSE American under the ticker symbol "AXTN." The completion of the offering depends on meeting the exchange's listing standards.

ThinkEquity serves as the underwriter for the offering. No public market currently exists for Akston Biosciences' common stock prior to this IPO.

The announcement was made in a press release statement from the company.

You May Also Be Interested In

• Uber nears EUR12.5B deal to acquire Delivery Hero - FT
• Greenland Mines updates Skaergaard resource estimate by 31%
• iPower plans to evaluate AI infrastructure hardware expansion